Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Immunology
Volume 2016, Article ID 8341751, 4 pages
http://dx.doi.org/10.1155/2016/8341751
Case Report

Successful Use of Plasma Exchange in the Treatment of Corticosteroid-Refractory Eosinophilic Granulomatosis with Polyangiitis Associated with Gastrointestinal Manifestations

Department of Clinical Immunology and Rheumatology, Kitano Hospital, The Tazuke Kofukai Medical Research Institute, Osaka 530-8480, Japan

Received 27 November 2015; Accepted 26 January 2016

Academic Editor: Christian Drouet

Copyright © 2016 Kohei Tsujimoto et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Comarmond, C. Pagnoux, M. Khellaf et al., “Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort,” Arthritis and Rheumatism, vol. 65, no. 1, pp. 270–281, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Guillevin, C. Pagnoux, R. Seror, A. Mahr, L. Mouthon, and P. Le Toumelin, “The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort,” Medicine, vol. 90, no. 1, pp. 19–27, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Casian and D. Jayne, “Plasma exchange in the treatment of Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and renal limited vasculitis,” Current Opinion in Rheumatology, vol. 23, no. 1, pp. 12–17, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. P. J. Klemmer, W. Chalermskulrat, M. S. Reif, S. L. Hogan, D. C. Henke, and R. J. Falk, “Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis,” American Journal of Kidney Diseases, vol. 42, no. 6, pp. 1149–1153, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Mukhtyar, L. Guillevin, M. C. Cid et al., “EULAR recommendations for the management of primary small and medium vessel vasculitis,” Annals of the Rheumatic Diseases, vol. 68, no. 3, pp. 310–317, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. A. T. Masi, G. G. Hunder, J. T. Lie et al., “The American college of rheumatology 1990 criteria for the classification of churg-strauss syndrome (allergic granulomatosis and angiitis),” Arthritis & Rheumatism, vol. 33, no. 8, pp. 1094–1100, 1990. View at Google Scholar · View at Scopus
  7. G. Assmann, M. Molinger, M. Pfreundschuh, R. Bohle, and V. Zimmer, “Gastrointestinal perforation due to vasculitis at primary diagnosis of eosinophilic granulomatosis with polyangiitis (EGPA) despite a high dose glucocorticosteroids treatment,” SpringerPlus, vol. 3, article 404, 2014. View at Publisher · View at Google Scholar
  8. C. C. Mok, C. S. Lau, and R. W. S. Wong, “Risk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy,” Arthritis & Rheumatism, vol. 41, no. 5, pp. 831–837, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Guillevin, O. Fain, F. Lhote et al., “Lack of superiority of steroids plus plasma exchange to steroids alone in the treatment of polyarteritis nodosa and Churg-strauss syndrome. A prospective, randomized trial in 78 patients,” Arthritis and Rheumatism, vol. 35, no. 2, pp. 208–215, 1992. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Guillevin, F. Lhote, P. Cohen et al., “Corticosteroids plus pulse cyclophosphamide and plasma exchanges versus corticosteroids plus pulse cyclophosphamide alone in the treatment of polyarteritis nodosa and churg-strauss syndrome patients with factors predicting poor prognosis. A prospective, randomized trial in sixty-two patients,” Arthritis and Rheumatism, vol. 38, no. 11, pp. 1638–1645, 1995. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Guillevin and C. Pagnoux, “Indications of plasma exchanges for systemic vasculitides,” Therapeutic Apheresis, vol. 7, no. 2, pp. 155–160, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Tsurikisawa, M. Taniguchi, H. Saito et al., “Treatment of Churg-Strauss syndrome with high-dose intravenous immunoglobulin,” Annals of Allergy, Asthma and Immunology, vol. 92, no. 1, pp. 80–87, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. M. G. Danieli, M. Cappelli, G. Malcangi, F. Logullo, A. Salvi, and G. Danieli, “Long term effectiveness of intravenous immunoglobulin in Churg-Strauss syndrome,” Annals of the Rheumatic Diseases, vol. 63, no. 12, pp. 1649–1654, 2004. View at Publisher · View at Google Scholar · View at Scopus